InMode Ltd. (INMD)

Business: InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.

IPO Date: 08-Aug-2019

Chief Financial Officer: Mr. Yair Malca

VP of Operations: Mr. Alon Yaari

Listing: NASDAQ: INMD

Country: Israel

Headquarters: Yokne'am,

Website: https://www.inmodemd.com

Market cap: $1,870.16 Mln

Revenue (TTM): $377.96 Mln

Earnings (TTM): $138.33 Mln

Cash: $399.46 Mln

Total Debt: $3.08 Mln

Insider's Holding: 16.62%

Liquidity: Low

52 Week range: $20.60 - 99.27

Shares outstanding: 83,081,104

6 Years Aggregate:

• CFO: $370.81 Mln
• EBITDA: $341.12 Mln
• Net Profit: $332.67 Mln